BCL-2 (B-cell lymphoma 2) ELISA

Code: BE51931

Tecan IBL International offers a comprehensive range of ELISAs, antibodies, immunoassays and recombinant proteins for research use only.



Enquire about this product
Add to Favourites
Price on Application

Bcl-2: Overview and Functions

Role in Cell Death Regulation:

  • Key Protein: Bcl-2 is a central protein in a gene family that regulates cell death (apoptosis) and survival.
  • Function: It inhibits programmed cell death without directly affecting cell proliferation. This inhibition helps maintain tissue homeostasis by balancing cell proliferation with cell death.
  • Mechanism: Bcl-2 is an intracellular membrane-associated protein that functions by preventing the apoptotic process.

Expression and Impact:

  • Normal Tissues: Bcl-2 is expressed in various hematopoietic cells, nonneoplastic epithelia, and some epithelial malignancies. It is typically present at low or undetectable levels in endothelial cells.
  • Effects of Altered Expression:
    • Reduced Levels: Lead to increased apoptosis and potential tissue damage.
    • Overexpression: Protects cells from apoptosis but does not cause immortalization or transformation into cancer cells by itself.

Role in Cancer and Oncogenesis:

  • Variable Expression: Different malignancies show varying levels of Bcl-2 expression, suggesting differential regulation.
  • Early Tumorigenesis: Bcl-2’s association with precancerous lesions indicates a role in the early stages of cancer development.
  • Bcl-2 Homologs: Recent research identifies several homologs of Bcl-2, some of which inhibit cell death while others promote apoptosis, thereby modulating Bcl-2’s protective effects.

Prognostic Significance and Therapeutic Implications:

  • Cancer Prognosis: Bcl-2 expression has prognostic value in various cancers, including:
    • Non-Hodgkin’s Lymphoma
    • Squamous Cell Carcinomas
    • Breast Carcinoma
    • Gallbladder Carcinoma
    • Thymoma
    • Multiple Myeloma
    • Acute Myeloid Leukemia
  • Therapy Resistance: Dysregulated Bcl-2 expression can impact the effectiveness of cancer therapies.
  • IL-2 Therapy Marker: Bcl-2 is also a potential marker for evaluating the effectiveness of IL-2 therapy, especially in AIDS patients.

Summary: Bcl-2 plays a critical role in regulating apoptosis and maintaining cell survival. Its expression levels can influence the development and progression of various cancers. While Bcl-2 overexpression does not directly transform normal cells, it is associated with cancer prognosis and resistance to treatments. Understanding Bcl-2 and its homologs can provide insights into tumorigenesis and therapeutic strategies.

This ELISA Kit from Tecan IBL International is for research use only.

Tecan IBL International offers a comprehensive range of ELISAs, immunoassays, antibodies and recombinant proteins.
Explore the full range >

Get our newsletter

Exciting news, new technologies, promotions, events, webinars and exclusive finds, straight to your inbox! Sign up for our newsletter.
We will protect your personal information. Read our privacy policy.